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Abstract
Current notions about mechanisms by which catch-up growth predisposes to later type 2 diabetes center upon
those that link hyperinsulinemia with an accelerated rate of fat deposition (catch-up fat). Using a rat model of
semistarvation-refeeding in which catch-up fat is driven solely by elevated metabolic efficiency associated with
hyperinsulinemia, we previously reported that insulin-stimulated glucose utilization is diminished in skeletal muscle
but increased in white adipose tissue. Here, we investigated the possibility that hyperinsulinemia during catch-up
fat can be contributed by changes in the secretory response of pancreatic beta-cells to glucose. Using the rat
model of semistarvation-refeeding showing catch-up fat and hyperinsulinemia, we compared isocalorically refed
and control groups for potential differences in pancreatic morphology and in glucose-stimulated insulin secretion
during in situ pancreas perfusions as well as ex vivo isolated islet perifusions. Between refed and control animals, no
differences were found in islet morphology, insulin content, and the secretory responses of perifused isolated islets
upon glucose stimulation. By contrast, the rates of insulin secretion from in situ perfused pancreas showed that
raising glucose from 2.8 to 16.7 mmol/l produced a much more pronounced increase in insulin release in refed
than in control groups (p < 0.01). These results indicate a role for islet secretory hyperresponsiveness to glucose in
the thrifty mechanisms that drive catch-up fat through glucose redistribution between skeletal muscle and adipose
tissue. Such beta-cell hyperresponsiveness to glucose may be a key event in the link between catch-up growth,
hyperinsulinemia and risks for later type 2 diabetes.
Introduction
A large body of evidence indicate that subjects who had
low birth weight or who showed reduced growth rate
during childhood, but who subsequently showed catch-
up growth, have higher susceptibility for type 2 diabetes
or cardiovascular diseases later in life [1-5]. While the
nature of this association between catch-up growth and
later disease risks remains obscure [6], it is intricately
linked to the state of hyperinsulinemia and accelerated
recovery of body fat (catch-up fat) that characterizes
catch-up growth [5-7]. There is a well-described rat
model of semistarvation-refeeding in which catch-up fat
and hyperinsulinemia occur in absence of hyperphagia
and could be linked to an elevated metabolic efficiency
due to suppressed thermogenesis [8]. Using this model,
we previously showed that insulin-mediated glucose uti-
lization is diminished in skeletal muscle but enhanced in
white adipose tissue [9], thereby suggesting that catch-
up fat is characterized by glucose redistribution from
skeletal muscle to adipose tissue. The suppressed ther-
mogenesis is thus associated with establishment of a
thrifty metabolism which spares glucose for catch-up fat
via coordinated induction of insulin resistance in skele-
tal muscle, insulin hyperresponsiveness in adipose tissue
and a state of hyperinsulinemia. In this context, putative
implication of insulin-secreting cells remains unknown.
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state of catch-up fat might also be contributed by pan-
creatic beta-cell hyperresponsiveness to glucose. To this
end, we investigated the semistarvation-refeeding rat
model for pancreatic endocrine function and morphol-
ogy. In particular, the secretory responses of perfused
pancreases and isolated islets were analyzed.
Methods
Animals and Diet
Male Sprague Dawley rats (Elevage Janvier, France),
caged singly in a temperature-controlled room (22 ±
1°C) with 12-h light/dark cycle, were maintained on
chow diet (Kliba, Cossonay, Switzerland) consisting, by
energy, of 24% protein, 66% carbohydrates, and 10% fat,
and had free access to tap water. Animals were main-
tained in accordance with our institute’s regulations and
guide for the care and use of laboratory animals.
Design of study
The experimental design is similar to that previously
described [8]. Seven wk old rats were food-restricted at
50% of their spontaneous food intake for 2 wks, after
w h i c ht h e yw e r er e f e dt h es a m ea m o u n to fc h o wc o r r e -
sponding to spontaneous chow intake of control rats
matched for weight at the onset of refeeding. Under
these conditions, the refed animals show similar gain in
lean mass, but 2-fold greater fat gain than controls, due
to 10-13% lower energy expenditure resulting from sup-
pressed thermogenesis [8]. Pancreatic function was
assessed on day 7 of refeeding, i.e. at a time-point when,
as shown in Figure 1, body fat in refed animals has not
yet exceeded that of controls, and when refed animals
showing catch-up fat exhibit normal glucose tolerance,
but are hyperinsulinemic as judged by higher plasma
insulin concentrations after a glucose load.
Pancreas perfusions (in situ)
To evaluate insulin-secretory capacity of the endocrine
pancreas, refed and control rats were anesthetized with
sodium pentothal and prepared for pancreas perfusion
as previously described [10]. Briefly, the pancreas was
perfused with a Krebs-Hank’s buffer (KHB) at a constant
rate of 5 ml/min via mesenteric and transileac arteries,
and the perfusate was collected every minute from a
catheter placed in the portal vein. After an initial equili-
bration period with no sample collected, the effluent
was collected in 1-min fractions from the portal vein.
The pancreas was perfused at 37°C with the KHB buffer
supplemented with the following concentrations of glu-
cose: period I (basal, last 4 min) 2.8 mmol/l glucose,
periods II and III (15 min each) 16.7 mmol/l glucose,
period IV (recovery, 15 min) 2.8 mmol/l glucose. Ali-
quots of perfusates were collected on ice and stored at
-20°C until insulin assay by radioimmunoassay (RIA)
using rat insulin as standard.
Isolated islet perifusions (ex vivo)
To evaluate the kinetics of insulin secretion in islet-
perifusion experiments, pancreatic islets were isolated by
collagenase digestion and handpicking from refed and
control rats as described previously [11]. Isolated islets
were cultured free-floating in RPMI 1640 medium
before experiments. Insulin levels were determined by
RIA and insulin secretion collected every min was nor-
malized per islet number. Islet perifusions were carried
out using 15 to 20 hand-picked islets per chamber of
250 μl volume thermostated at 37°C (Brandel, Gaithers-
burg, MD, USA). The flux was set at 0.5 ml/min and
fractions were collected every min following a 20-min
washing period at basal glucose. Rat islets were peri-
fused with Krebs-Ringer bicarbonate HEPES buffer at
basal 2.8 mmol/l glucose for 20 min, then stimulated
with 8.0 mmol/l glucose (20 min) and 16.7 mmol/l glu-
cose (20 min), returning to 2.8 mmol/l glucose (last 10
min).
Immunohistochemistry
Pancreata were harvested in cold PBS and treated over-
night at 4°C in 4% paraformaldehyde before embedding
in paraffin and 5 μm-thick tissue sections were mounted
on adhesive-coated slides. Pancreata sections were incu-
bated with a diluted primary antibody for 2 hours at
room temperature, and with an appropriate Cy3-
(Jackson ImmunoResearch Laboratories, Inc, West-
G r o v e ,P A ,U S A )o rA L E X A - c o n j u g a t e d( M o l e c u l a r
Probes, Inc., Eugene, OR, USA) anti IgG serum for 1
hour. The antibodies and their dilution used in the pre-
sent analysis were as follows: guinea pig anti-insulin
(Dako, Carpinteria, CA, USA; dilution 1/400), rabbit
anti-glucagon (Dako, Carpinteria, CA, USA; dilution
1/100). Sections were analyzed on a Zeiss Axiophot
microscope equipped with an Axiocam color CCD cam-
era (Carl Zeiss, Feldbach, Switzerland).
Statistics
Data are expressed as mean ± SE, and were analyzed by
either unpaired t-test or analysis of variance, using
computer software STATISTIK 8 (Analytical Software,
St. Paul, Minnesota).
Results
Pancreatic perfusions (in situ)
Figure 2 (panel a) shows the profiles of insulin secretion
assessed by in situ perfusion of intact pancreas from
refed and control animals on day 7 of refeeding. Raising
glucose (Glc) from 2.8 to 16.7 mmol/l led to a much
more pronounced increase in insulin release as a
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Page 2 of 7function of time in refed rats than in controls. The area
under the curve (AUC), calculated after subtraction of
basal release and shown in Figure 2 (panel b), was
g r e a t e rb y3 -a n d4 - f o l di nt h ef i r s ta n ds e c o n d1 5m i n
period respectively, in refed than in control animals (P <
0.01, by Student’s t-test). During the recovery period
(upon shifting back to 2.8 mmol/l glucose), the differ-
ences in insulin secretion between the two groups were
markedly attenuated and no longer significant.
Isolated islet perifusions (ex vivo)
The kinetics of insulin secretion in islet-perifusion
experiments, shown in Figure 2 (panel c and d)
indicated that, once isolated, islets from refed and
control animals responded similarly to 8.0 and 16.7
mmol/l glucose.
Islets and whole pancreas
No between-group differences were found in wet weight
of fresh pancreases (2.77 ± 0.58 vs 2.49 ± 0.55 g) and in
total insulin content (342 ± 55 vs 340 ± 58 μg insulin
per g tissue) comparing control and refed animals
respectively. Furthermore, immunohistochemistry
revealed that islets of refed rats were normal, exhibiting
similar beta-cell distribution and size than controls
(Figure 3).
Figure 1 Rat model of catch-up fat and hyperinsulinemia. Panels a and b show data (mean ± SE, n = 6) for body weight and body fat,
respectively, at the end of semistarvation (corresponding to day 0 of refeeding), and at day 7 and 14 of refeeding in refed and control groups
consuming isocaloric amounts of food. After sacrifice, the whole carcasses were dried to a constant weight in an oven maintained at 70°C and
subsequently homogenized for analysis of fat content by the Soxhlet extraction method as previously described (8). No between-group
differences are found in dry lean tissue mass at all time-points; ** p < 0.01; *** p < 0.001. Panels c and d show data (mean ± SE, n = 6) for
plasma glucose and insulin before and after an intraperitoneal glucose tolerance test (GTT), which was performed as previously described (8) on
day 7 of refeeding, by ip administration of 2 g glucose /kg body weight. Plasma glucose was determined using a Beckman glucose analyzer,
while plasma insulin was assessed using rat insulin ELISA kit (Crystal Chem Inc, IL, USA); **: p < 0.01
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No between-group differences were found in plasma
concentrations of glucagon-like peptide 1, gastric inhibi-
tory peptide, or leptin (Table 1). By contrast, plasma
adiponectin concentrations were higher in the refed
animals than in controls (p < 0.01).
Discussion
Beta-cell function was investigated in a rat model of
semistarvation-refeeding in which a high metabolic effi-
ciency for body fat recovery (i.e., thrifty metabolism
driving catch-up fat) is intricately associated with hyper-
insulinemia [8]. Data show that the hyperinsulinemic
c
0
10
20
30
40
50
1 1 01 92 83 74 65 5
Time [min]
P
e
r
i
f
u
s
i
o
n
[
p
g
i
n
s
u
l
i
n
/
i
s
l
e
t
]
16.7 mM Glc
8 mM Glc
Islet perifusion
d
100
150
0
50
2.8mM Glc 8mM Glc 16.7mM Glc
P
e
r
i
f
u
s
i
o
n
A
U
C



a
0
10
20
30
40
50
11 0 1 9 2 8 3 7 4 6
Time [min]
P
e
r
f
u
s
i
o
n
 
[
n
g
i
n
s
u
l
i
n
/
m
l
]
Control
Refed
16.7 mM Glc
**************
Pancreatic perfusion
b
0
50
100
150
200
2.8mM Glc 16.7mM Glc
1st period
16.7mM Glc
2nd period
P
e
r
f
u
s
i
o
n
 
A
U
C
 
 
Control
Refed




*
*
Figure 2 Kinetics of insulin secretion. Panel a shows the kinetics of insulin secretion from in situ perfusion of pancreas in response to glucose
(Glc) in refed and control animals (n = 6) on day 7 of refeeding, first in response to 2.8 mM glucose (baseline), followed by two successive
periods lasting 15 min each in response to 16.7 mmol/l glucose before switching back to 2.8 mmol/l glucose. Panel b shows the area under the
curve (AUC) for each time-period, calculated after subtraction of basal release. All values are mean ± SE. Symbols for statistical significance of
differences are as follows: panel a: * p < 0.05 (at least) between refed and control for corresponding time points; Panel b: * p < 0.05: between-
group comparison (refed vs control) for AUC within 1
st or 2
nd period; § p < 0.05; §§p < 0.01: within-group comparison between 16.7 mM Glc or
8 mM relative to basal 2.8 mM Glc. Panel c indicates the kinetics of insulin secretion from ex vivo perifusion of islets isolated from pancreases of
refed and control groups (n = 5) on day 7 of refeeding, first in response to 2.8 mmol/l glucose (baseline), followed by two successive periods of
17 min with 8 and 16.7 mmol/l glucose, respectively, before switching back to 2.8 mmol/l glucose; panel d shows the AUC for each time-period,
calculated after subtraction of basal release. Panel d shows the area under the curve (AUC) for each time-period, calculated after subtraction of
basal release All values are mean ± SE. Symbols for statistical significance of differences in panel b are as follows: § p < 0.05: within-group
comparison between 16.7 mM Glc or 8 mM Glc relative to basal 2.8 mM Glc
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Page 4 of 7state of catch-up growth is characterized at the beta-cell
level by enhanced secretory response to glucose stimula-
tion. No difference was observed between refed and
controls in the weight of the pancreas, pancreatic islet
morphology or insulin content. Accordingly, pancreatic
insulin hypersecretion during catch-up growth cannot
be attributed to an increase in beta-cell mass or pan-
creatic insulin content and hence in functional cells, but
rather resides primarily in an in situ beta-cell
hyperresponsiveness.
Interestingly, such insulin hypersecretion during
catch-up growth was observed in the in situ pancreatic
perfusion preparation, although not in isolated islets.
Therefore, hyperresponsiveness cannot be explained by
intra-cellular alterations in metabolism-secretion cou-
pling per se nor in the insulin exocytosis mechanisms.
The observed phenomenon is likely to reside in differen-
tial modulation of the secretory response, possibly
through negative modulators of insulin secretion being
repressed during catch-up growth, resulting in the
observed hyperresponsiveness of the pancreatic response
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Figure 3 Pancreatic islet morphology and insulin content. Panels a and b are pancreata sections stained with hematoxylin and eosin (H+E)
showing islets and acinar cells in control and refed rats, respectively. Panel c and d are immunostainings of insulin (in green) and glucagon (in
red) showing representative islets from control and refed rats, respectively.
Table 1 Plasma concentrations of hormones on day 7 of
refeeding
Control Refed t-test
Glucagon-like peptide-1 (ng/ml) 0.28 ± 0.02 0.24 ± 0.02 NS
Gastric inhibitory peptide (ng/ml) 0.49 ± 0.04 0.55 ± 0.07 NS
Leptin (ng/ml) 1.91 ± 0.10 2.17 ± 0.18 NS
Adiponectin (μg/ml) 7.34 ± 0.41 11.7 ± 1.60 p < 0.01
All values are mean ± SE (n = 6); NS: no significant differences.
The hormones were assayed by commercial ELISA kits from tail blood
collected after a 5-6 h fast.
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Page 5 of 7to glucose. Such in situ islet tuning could be contributed
by neuro-hormonal effectors (e.g glucagon-like peptide 1
[12]), paracrine systems (e.g. dopamine [13,14]), or even
composition of surrounding fatty acids [15], all these
factors being lost once islets are isolated.
The pancreatic insulin hypersecretion during catch-up
g r o w t hi s ,h o w e v e r ,u n l i k e l yb ea t t r i b u t e dt og l u c a g o n -
like peptide 1 and gastric inhibitory peptide since these
incretins did not differ in refed and control groups in
the post-absorptive state (Table 1) nor after a glucose
l o a d( d a t an o ts h o w n ) .I ti sa l s ou n l i k e l yt ob ec o n s e -
quential to excess adiposity and the associated elevation
in circulating leptin since our between-group compari-
son was conducted on day 7 of refeeding, i.e. at a
time-point when body fat and plasma leptin in the refed
animals had not yet exceeded those of controls (see
Figure 1, panel b and Table 1), respectively. Whether
our findings of an elevated plasma adiponectin in the
refed group versus controls (Table 1) can be implicated
in the increased pancreatic hyperresponsiveness to glu-
cose is at present unknown. This is an avenue for
further research, particularly in the light of emerging
evidence that adiponectin may act directly on pancreatic
beta-cells to enhance insulin secretion [16].
Whatever the mechanisms that lead to such beta-cell
hyperresponsiveness to glucose during catch-up growth,
its demonstration in a rat model in which catch-up fat
is driven solely by suppressed thermogenesis (and not
hyperphagia) suggests a role for pancreatic islets in the
thrifty mechanisms that drive catch-up fat through glu-
cose redistribution between skeletal muscle and adipose
tissue [8,9,17,18]. This is depicted in a conceptual model
presented in the Figure 4.
An enhanced beta-cell function, as evidenced by an
increased insulin release in response to glucose stimula-
tion, has been observed early in the pathogenesis of type 2
diabetes in animal models [19-21]. It has also been shown
to be an early characteristic of ethnic groups and people
with normal glucose tolerance at higher risks for diabetes
[22-27], and is embodied in the concept that b-cell hyper-
function is an early stage in the progression to b-cell fail-
ure [28]. The pancreatic b-cell hyperresponsiveness to
Figure 4 Model depicting thrifty metabolism underlying catch-up fat and hyperinsulinemia during catch-up growth. In response to fat
depletion and/or delayed fat stores expansion (resulting from energy deficit and growth retardation), energy conservation mechanisms operate
via suppressed thermogenesis [8], leading to diminished insulin sensitivity in skeletal muscle [9,17] during increased food availability, so that the
spared energy leads to accelerated replenishment of the fat stores (catch-up fat) in adipose tissue. The glucose spared from utilization in skeletal
muscle is thus redirected to an adipose tissue that shows increased insulin hyperresponsiveness [9] and enhanced lipogenic machinery [18],
under orchestration by hyperinsulinemia which is sustained by pancreatic b-cell hyperresponsiveness (as reported here). In this model, the
‘adipostat’ signals (?) that dictate suppress thermogenesis and insulin resistance in skeletal muscle are postulated to also dictate the pancreatic
beta-cell hyperresponsiveness that will sustain glucose redistribution between skeletal muscle and adipose tissue, thereby contributing to the
thrifty ‘catch-up fat’ phenotype associated with hyperinsulinemia.
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Page 6 of 7glucose during catch-up fat may therefore be a key
component in the link between catch-up growth and later
risks for type 2 diabetes.
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